Position in LRMR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$133,645
-$302,904 QoQ
Shares Held
29,699
-74.1% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. LRMR ranks #351 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in LRMR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $133,645 | 29,699 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $436,549 | 114,580 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $833,335 | 257,999 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $313,093 | 108,337 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $96,556 | 44,910 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $205,616 | 53,131 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $130,174 | 19,874 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $128,122 | 17,672 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $201,878 | 26,598 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $127,577 | 28,039 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $55,509 | 14,053 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $89,784 | 28,685 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,916 | 5,942 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $297 | 72 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $10,703 | 3,345 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,177 | 601 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $7,018 | 1,733 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,095 | 1,121 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $92 | 8 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $78 | 8 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $116 | 8 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,401 | 299 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||